Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Engineering Large-Scale and Innervated Functional Human Gut for Transplantation

ABSTRACT: Engineering Large-Scale and Innervated Functional Human Gut for Transplantation

PROVIDER: PRJNA976273 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24742081.fastq.gz	Fastqsanger.gz
	SRR24742082.fastq.gz	Fastqsanger.gz
	SRR24742083.fastq.gz	Fastqsanger.gz
	SRR24742084.fastq.gz	Fastqsanger.gz
	SRR24742085.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Engineering large-scale perfused tissues via synthetic 3D soft microfluidics

Project description:Engineering large-scale perfused tissues via synthetic 3D soft microfluidics

| PRJNA751477 | ENA

Engineering Large-Scale and Innervated Functional Human Gut for Transplantation

Project description:In this study, we utilize a scaffolding tray for organoid development. Conventional organoids are compared to those generated using the scaffolding tray.

2023-12-01 | GSE233439 | GEO

Engineering large-scale perfused tissues via synthetic 3D soft microfluidics

Project description:The vascularization of engineered tissues and organoids has remained a major unresolved challenge in regenerative medicine. While multiple approaches have been developed to vascularize in vitro tissues, it has thus far not been possible to generate perfusable vessels in sufficiently close proximity and at sufficient small scale to perfuse large de novo tissues. Here, we achieve the perfusion of multi-mm3 tissue constructs by generating perfusable synthetic capillary-scale 3D channels. Our 3D soft microfluidic strategy is uniquely enabled by a 3D-printable 2-photon-polymerizable hydrogel formulation, which allows for precise microvessel printing at scales below the diffusion limit. We demonstrate that these large-scale engineered tissues are viable, proliferative and exhibit complex morphogenesis during long-term in-vitro culture, while avoiding hypoxia and necrosis. We show by scRNAseq and immunohistochemistry that neural differentiation is significantly accelerated in perfused neural constructs. Additionally, we illustrate the versatility of this platform by demonstrating long-term perfusion of developing liver tissue. This fully synthetic vascularization platform opens the door to the generation of human tissue models at unprecedented scale and complexity.

2022-08-02 | GSE181290 | GEO

Engineering an inducible leukemia-associated transcription factor enables large-scale ex vivo production of functional human phagocytes

Project description:Engineering an inducible leukemia-associated transcription factor enables large-scale ex vivo production of functional human phagocytes

| PRJNA996892 | ENA

NHGRI Large Scale Sequencing Program

Project description:NHGRI Large Scale Sequencing Program

| PRJNA158497 | ENA

Large-Scale CLL Genome Analysis

Project description:Large-Scale CLL Genome Analysis

| PRJNA80303 | ENA

Large-scale swine wastewater

Project description:Large-scale swine wastewater Raw sequence reads

| PRJNA1152766 | ENA

Large Scale Genotyping of Psychiatric Disorders

Project description:Large Scale Genotyping of Psychiatric Disorders

| PRJNA394934 | ENA

Engineering an inducible leukemia-associated transcription factor enables large-scale ex vivo production of functional human phagocytes

Project description:Ex vivo expansion of human CD34+ hematopoietic stem and progenitor cells remains a challenge due to rapid differentiation after detachment from the bone marrow niche. In this study, we assessed the capacity of an inducible transcription factor to enable sustained ex vivo proliferation of hematopoietic precursors and their capacity to differentiate into functional phagocytes. We fused the coding sequences of an FK506-Binding Protein 12 (FKBP12)-derived destabilization domain (DD) to the myeloid/lymphoid lineage leukemia/eleven nineteen leukemia (MLL-ENL) transcription factor to generate the fusion protein DD-MLL-ENL and retrovirally expressed the protein switch in human CD34+ progenitors. Using Shield1, a chemical inhibitor of DD fusion protein degradation, we established large-scale and long-term expansion of late monocytic precursors. Upon Shield1 removal, the cells lost self-renewal capacity and spontaneously differentiated, even after 2.5 years of continuous ex vivo expansion. In the absence of Shield1, stimulation with IFN-γ, LPS, and GM-CSF triggered terminal differentiation. Gene expression analysis of the obtained phagocytes revealed marked similarity with naïve monocytes. In functional assays, the novel phagocytes migrated towards CCL2, attached to VCAM-1 under shear stress, produced reactive oxygen species, and engulfed bacterial particles, cellular particles and apoptotic cells. Finally, we demonstrated Fcγ receptor recognition and phagocytosis of opsonized lymphoma cells in an antibody-dependent manner. Overall, we have established a novel transcription factor that, as a single factor, is useful for large-scale ex vivo production of human phagocytes. Such adjustable transcription factors have the potential to be applied as molecular tools to produce functional immune cells for cell therapy.

2024-05-22 | GSE237826 | GEO

Large-scale genomic study reveals robust activation of the immune system following advanced Inner Engineering meditation retreat

Project description:Large-scale genomic study reveals robust activation of the immune system following advanced Inner Engineering meditation retreat

| PRJNA728117 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data